Your session is about to expire
← Back to Search
Preoperative Maltodextrin for Heart Failure
Study Summary
This trial is testing whether a Maltodextrin solution can improve cardiac function in patients with a reduced left ventricular ejection fraction who are about to have coronary artery bypass grafting surgery. The trial is double-blinded, meaning that neither the patients nor the researchers will know which patients are receiving the Maltodextrin solution until after the trial is over.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You cannot swallow or tolerate taking medicine by mouth.I am 18 years old or older.I have difficulty swallowing.I have celiac disease.I have been diagnosed with gastroparesis.I am scheduled for surgery to improve blood flow to my heart.Your heart's pumping ability is less than 50% before surgery.I have Type 1 diabetes.
- Group 1: Intervention Group
- Group 2: Placebo Group
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers still recruiting for this experiment?
"Clinicaltrials.gov does not list this trial as currently recruiting, which is consistent with the last edit to the study's page being made on August 26th 2022. However, there are 1,344 medical research studies actively enrolling patients at present."
What is the main purpose of this research endeavor?
"The primary outcome of this research is to ascertain the feasibility of patients having a preoperative drink within an appropriate timeframe. Secondary objectives are length of ICU stay, insulin sensitivity measured by glucose infusion rate after one hour of hyperinsulinemic-euglycemic clamping, and post-surgery insulin requirements."
To what degree is Maltodextrin solution hazardous to patients?
"There is ample evidence of Maltodextrin solution's safety, thus it acquired a score of 3."
What is the overall participation rate in this experiment?
"Sadly, this trial has concluded its search for participants. It was first posted on April 1st 2023 and the last update occurred August 26th 2022. If you are seeking alternate trials related to insulin resistance, 1341 studies are enrolling patients at present and 3 clinical trials are looking for volunteers who would take Maltodextrin solution."
Could you elucidate on any additional investigations which have included Maltodextrin solution?
"Presently, there are three research projects underway for Maltodextrin solution. None of these trials have reached stage 3 yet and all the conducted tests take place in Ann Arbor, Michigan across 3 different medical centres."
Share this study with friends
Copy Link
Messenger